Back to results
US 6,730,683 B2Granted
Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
AssigneeSmithKline Beecham Corporation
InventorsTimothy Francis Gallagher, Jeffrey Charles Boehm, Jerry Leroy Adams
Life of this patent
Estimating the term…
Abstract
Novel 1,4,5-substituted imidazole compounds and compositions for use in therapy as cytokine inhibitors.
Claims19
A compound which is:
- 1-Cyclohexyl-4-(4-fluorophenyl)-5-[(2-phenylamino)pyrimidin-4-yl]imidazole;
- 1-Cyclohexyl-4-(4-fluorophenyl)-5-[[2[N-(3-morpholino)propyl]amino]pyrimidin-4-yl]imidazole;
- 1-Cyclohexyl-4-(4-fluorophenyl)-5-[[2-[N-(2-imidazol-4-yl)ethyl]amino]pyrimidin-4-yl]imidazole;
- 1-Cyclohexyl-4-(4-fluorophenyl)-5-[[2-[N-(3-pyridyl)methyl]amino]pyrimidin-4-yl]imidazole;
- 1-Cyclohexyl-4-(4-fluorophenyl)-5-[[2-[N-(3,3-diphenyl)propyl]amino]pyrimidin-4-yl]imidazole;
- (+/−)-1-Cyclohexyl-4-(4-fluorophenyl)-5-[[2-[N-(1-methyl-3-phenyl)propyl]amino]pyrimidin-4-yl]imidazole;
- N-4-[[[4-(4-Fluorophenyl)]-5-[[2-[(3-trifluoromethyl)phenyl]amino]]pyrimidine-4-yl]imidazol-4-yl]piperdinyl-N′-[(3-trifluoromethyl)phenyl]urea;
- N-[2-[4-(4-Fluorophenyl)-5-[[2-(3,4-dichlorobenzyl)pyrimidin-4-yl]-1 H-imidazol-1-yl]ethyl]-3,4-dimethoxybenzamide;
- N-[2-[4-(4-Fluorophenyl)-5-[[2-(4-methoxybenzylamino)pyrimidin-4-yl]-1 H-imidazol-1-yl]ethyl]-ethoxyacetamide;
- 1-Isopropyl-4-(4-fluorophenyl)-5-[2-phenylamino-pyrimidin-4-yl]imidazole;
- 1-Cyclopentyl-4-(4-fluorophenyl)-5-[2-phenylamino-pyrimidin-4-yl]imidazole;
- 1-[(1-t-Butoxycarbonyl)-4-piperidinyl]-4-(4-fluorophenyl)-5-[2-(2-methyl-4-fluorophenyl)amino]pyrimidin-4-yl]imidazole;
- 1-(4-Piperidinyl)-4-(4-fluorophenyl)-5-[2-(2-methyl-4-fluorophenyl)-amino]pyrimidin-4-yl]imidazole;
- 1-(4-Piperidinyl)-4-(4-fluorophenyl)-5-[2-(2-methyl-5-fluorophenyl)amino]pyrimidin-4-yl]imidazole;
- 1-(4-Piperidinyl)-4-(4-fluorophenyl)-5-[2-(2,6-dimethylphenyl)amino]pyrimidin-4-yl]imidazole;
- 1-(4-Piperidinyl)-4-(4-fluorophenyl)-5-[2-(2-methylphenyl)amino]pyrimidin-4-yl]imidazole;
- 1-(4-Fluorophenyl)-4-(4-fluorophenyl)-5-[2-phenylamino-pyrimidin-4-yl]imidazole;
- 1-(4-Fluorophenyl)-4-(4-fluorophenyl)-5-[2-(4-fluorophenylamino)-pyrimidin-4-yl]imidazole;
- 1-(4-Fluorophenyl)-4-(4-fluorophenyl)-5-[2-(4-methylphenylamino)-pyrimidin-4-yl]imidazole;
- 1-(4-Fluorophenyl)-4-(4-fluorophenyl)-5-[2-(2-methylphenylamino)pyrimidin-4-yl]imidazole;
- 1-(4-Fluorophenyl)-4-(4-fluorophenyl)-5-[2-(2,6-dimethylphenylamino)pyrimidin-4-yl]imidazol;
- 1-(4-Fluorophenyl)-4-(4-fluorophenyl)-5-[2-(4-2-morpholinylphenylamino)-pyrimidin-4-yl]imidazole;
- or a pharmaceutically acceptable salt thereof.
20 more elements
A process for producing a compound of the formula:
- wherein:
- Cmpd. No. R2 Ra 1 cyclohexyl phenyl 2 cyclohexyl 3 cyclohexyl 4 cyclohexyl 5 cyclohexyl (3,3-diphenyl)propyl 6 cyclohexyl (1-methyl-3-phenyl)propyl 7 (3-trifluoromethyl)phenyl 8 (3,4-dimethoxybenzamide ethyl 3,4-dichlorobenzyl 9 ethoxyacetamide-ethyl 4-methoxybenzyl 10 isopropyl phenyl 11 cyclopentyl phenyl 12 (1-t-butoxycarbonyl)-4-piperidinyl (2-methyl-4-fluorophenyl) 13 4-piperidinyl (2-methyl-4-fluorophenyl) 14 4-pipendinyl (2-methyl-5-fluorophenyl) 15 4-piperidinyl (2,6-dimethylphenyl) 16 4-piperidinyl (2-methylphenyl) 17 4-fluorophenyl phenyl 18 4-fluorophenyl (2-methylphenyl) 19 4-fluorophenyl (2,6-dimethylphenyl) 20 4-fluorophenyl *denoting point of attachment;
- which process comprises reacting a compound of the formula:
- with a compound of the formula:
- wherein R is a substituted or unsubstituted C 1-4 alkyl;
- Ar is an unsubstituted or substituted aryl;
- R2 is as defined above, and p is =2;
- to yield a compound of the formula:
- wherein R and R2 are as defined above;
- and using oxidizing conditions to make the corresponding sulfone or sulfoxide derivative;
- and using displacement conditions reacting the corresponding sulfone or sulfoxide derivative with the desired NH2Ra moiety, or a metal precursor thereof, to yield a compound as defined in the table above.
8 more elements
The compound 1-(4-Piperidinyl)-4-(4-fluorophenyl)-5-[2-(2-methylphenyl)amino]pyrimidin-4-yl]imidazole;
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising 1-(4-Piperidinyl)-4-(4-fluorophenyl)-5-[2-(2-methylphenyl)amino]pyrimidin-4-yl]imidazole, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
Dependencies are inferred from the claim text.